Apyx Medical

Apyx Medical is a publicly traded medical technology company focused on developing and commercializing advanced energy systems for surgical and aesthetic procedures. Its primary achievement is the Renuvion platform, which utilizes helium plasma technology for controlled tissue effects. The company's strategy involves expanding the clinical indications for Renuvion, launching its next-generation AYON system, and leveraging its OEM segment for manufacturing revenue. Apyx aims to establish its technology as a standard of care in targeted surgical markets.

Proprietary Helium Plasma Technology that utilizes radiofrequency energy to ionize helium gas, creating a precise, cold plasma beam for cutting, coagulation, and ablation of tissue with controlled thermal effect.

Apyx faces intense competition from large, well-capitalized medical device giants like Medtronic and Johnson & Johnson in the surgical market, and from established aesthetic technology players like InMode and Solta Medical. Its differentiation relies on proving the clinical advantages of its proprietary helium plasma technology over traditional electrosurgical and thermal-based devices.